Evidence map›Paper›PMID 41876826›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026

Putative glymphatic function and free water in schizophrenia: A 7T DTI study across psychosis stages.

Guitao Qi, Yuanchao Zhang, Yingqi Laetitia Wang, Freeha Anjum, Jean Theberge, Yuchao Jiang, Ali Khan, Lena Palaniyappan

Abstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Guitao Qi *The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, University of Electronic Science and Technology of China, Chengdu, PR China.
Yuanchao Zhang *The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, University of Electronic Science and Technology of China, Chengdu, PR China.ORCID http://orcid.org/0000-0001-8191-4899
Yingqi Laetitia WangNeuroscience Graduate Program, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Freeha AnjumIntegrated Program in Neuroscience, McGill University, Montreal, QC, Canada.
Jean ThebergeLawson Imaging Research Program, Lawson Health Research Institute, London, ON, Canada.ORCID http://orcid.org/0000-0001-7578-4469
Yuchao JiangSchool of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen, PR China.
Ali KhanRobarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Lena PalaniyappanRobarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada. lena.palaniyappan@mcgill.ca.ORCID http://orcid.org/0000-0003-1640-7182

Funding

National Natural Science Foundation of China (National Science Foundation of China) No. 82202242
6 · The paper itself

Abstract

Schizophrenia is characterized by impaired brain health, including gray matter reductions and cognitive dysfunction, with vascular and glymphatic dysfunction emerging as key contributors. The glymphatic system, which clears metabolic waste via perivascular pathways, is measurable using Diffusion Tensor Imaging-Along the Perivascular Space (DTI-ALPS) and its dysfunction is suspected to increase extracellular free water (FW). Prior studies reported potential glymphatic impairment in schizophrenia, but its relationship to the stage of illness and impact on interstitial fluid dynamics remains unclear. This study employed ultra-high field (7-Tesla) DTI to quantify DTI-ALPS and FW in white and gray matter in 125 subjects, including clinical high-risk (CHR), untreated first-episode psychosis (FEP), established schizophrenia (>3 years), and healthy controls (HC). We investigated: (1) the presence of DTI-ALPS alterations in CHR and its relative magnitude across disease stages; (2) its association with symptom severity; (3) its correlation with FW; and (4) its relationship to likely origins of neuroanatomical progression in schizophrenia from the hippocampal region. Compared with HC, the established, FEP and CHR all showed lower DTI-ALPS (p < 0.01 for all, Hedge's g = 0.73-1.13) and higher white matter FW (p < 0.05 for all, g = 0.59-1.57). Lower DTI-ALPS was correlated with higher FW, longer duration of untreated psychosis, and was selectively pronounced in the FEP subgroup, whose structural changes may originate from the hippocampal region. Our findings suggested that the putative glymphatic dysfunction indexed by DTI-ALPS predates antipsychotics, drives interstitial fluid accumulation, and contributes to schizophrenia's structural and clinical progression, offering mechanistic insights into its pathophysiology.

Indexed as

BrainGlymphatic SystemPsychotic DisordersSchizophreniaAdolescentAdultDiffusion Tensor ImagingDisease ProgressionFemaleGray MatterHumansMaleWhite MatterYoung Adult

Identifiers

PMID41876826
PMCPMC13291166

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.